Existing investors Hygea VCT and Oxford Technology VCT have further invested in drug company Glide Pharma as part of a £2.7m fourth round of funding, alongside Oxford Capital Partners and private backers.
France-based luxury holiday company is aiming for market consolidation following the fresh funding
Advisory firm’s first office in continental Europe will be led by director George Lyons
German centre-based tutoring provider will operate individually while synergies with new owner are identified
GP in informal discussions around exit or sale of parts of the UK-based company